Recent Content
-
Seeking Alpha: Carlyle Group: Undervalued With Improving Technicals
-
_thumb.png)
Will the Retail Rout Continue? Key Companies Report Q1 Results
-
Investing.com: Will Retail Rout Continue? Key Companies Report Q1 Results
-
Leveraging ETF Calendar Data: Finding Alpha and Managing Risk
-
Seeking Alpha: Atlas Corp. Shares At Key Support Ahead Of Q1 Earnings
-
_thumb.png)
Earnings Update: Volatility Persists as Consumers Keep Spending
-
NXTmine: Corporate Earnings Update: Consumers Keep Spending Amidst Volatility
-
Seeking Alpha: PPL Shares With Relative Strength Despite Bad News In 2022
-
_thumb.png)
Data Minds: Capitalizing on Global Event-Driven Data | May 3, 2022 [Recording Available]
-
Traders' Insight: Peak Earnings Season: Energy Stocks Set to Report Big Profits
WSH Incorporates Drug Approval Dates from BioMedTracker for Pharma Traders
Event date information provider Wall Street Horizon has added US Food and Drug Administration drug approval dates and related events from Informa subsidiary BioMedTracker to its Enchilada platform, to meet investor demand for market-moving information on pharmaceutical stocks.
Access full article
